Stockreport

MorphoSys reports Q1 results [Seeking Alpha]

MorphoSys AG - American Depositary Shares  (MOR) 
PDF As a consequence of the sale and transfer of tafasitamab to Incyte on February 5, 2024, MorphoSys' 2024 financial guidance published on January 30, 2024, cannot be main [Read more]